Reaction
Age-Related Macular Degeneration reporting signals
As of the last recalculation, Age-Related Macular Degeneration appears in 1,508 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 327.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 445 | 327.8 | 333.4 |
| Aflibercept | 139 | 67.6 | 67.9 |
| Faricimab | 15 | 25.8 | 25.8 |
| Bevacizumab | 131 | 15.9 | 15.9 |
| Brinzolamide | 7 | 11.2 | 11.2 |
| Polatuzumab Vedotin | 6 | 8.5 | 8.5 |
| Timolol | 5 | 5.7 | 5.7 |
| Travoprost | 3 | 4.8 | 4.8 |
| Abemaciclib | 5 | 3.5 | 3.5 |
| Crizotinib | 3 | 3.3 | 3.3 |